MARÍA ÁNGELES
NAVAS HERNÁNDEZ
Profesora titular de universidad
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (10)
2023
-
Effect of rapamycin on lysosomal accumulation in a CRISPR/Cas9-based cellular model of VPS13A deficiency
Journal of Cellular and Molecular Medicine, Vol. 27, Núm. 11, pp. 1557-1564
2021
-
A conserved ATG2 binding site in WIPI4 and yeast Hsv2 is disrupted by mutations causing β-propeller protein-associated neurodegeneration
Human molecular genetics, Vol. 31, Núm. 1, pp. 111-121
-
The WIPI Gene Family and Neurodegenerative Diseases: Insights From Yeast and Dictyostelium Models
Frontiers in Cell and Developmental Biology, Vol. 9
2020
-
A novel reverse two-hybrid method for the identification of missense mutations that disrupt protein–protein binding
Scientific Reports, Vol. 10, Núm. 1
2018
-
Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 7, pp. 2385-2394
2015
-
Lack of glibenclamide response in a case of permanent neonatal diabetes caused by incomplete inactivation of glucokinase
JIMD Reports (Springer), pp. 21-26
2012
1996
-
The regulatory characteristics of yeast fructose-1,6-bisphosphatase confer only a small selective advantage
Journal of Bacteriology, Vol. 178, Núm. 7, pp. 1809-1812
1994
-
Catabolite inactivation of heterologous fructose‐1,6‐bisphosphatases and fructose‐1,6‐bisphosphatase‐β‐galactosidase fusion proteins in Saccharomyces cerevisiae
European Journal of Biochemistry, Vol. 222, Núm. 3, pp. 879-884
1993
-
Futile cycles in Saccharomyces cerevisiae strains expressing the gluconeogenic enzymes during growth on glucose
Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, Núm. 4, pp. 1290-1294